740. Successful Implementation of an Electronic Pneumococcal Vaccine Protocol for Better Promotion of Pneumococcal Vaccine Administration and Compliance in a Tertiary Care Facility.
Session: Poster Abstract Session: Vaccines: Improving Delivery
Thursday, October 27, 2016
Room: Poster Hall
Posters
  • pneumovas 4X8 (1) (2) revised.pdf (758.3 kB)
  •  

     

    Background:

    In 2014 the Center for disease control and prevention’s Advisory Committee on Immunization Practices (CDC ACIP) updated its vaccine guidelines and recommended the administration of a 13-valent pneumococcal conjugate vaccine (PCV13) in series with the 23-valent pneumococcal polysaccharide vaccine (PPSV23) for adults >65 year and adults 19-65 year with high risk conditions. As a part of this core measure we implemented an updated electronic medical record(EMR) protocol that aides the nursing staff (NS) to screen and immunize eligible patients. The aim of our study is to analyze the effect of this new protocol on vaccination rate and compliance.

    Methods:

    This study was conducted in 8 hospital tertiary care facility in Detroit. The pneumococcal vaccine assessment protocol (PVAP) was launched in October 2015, which is a user friendly electronic guideline compliant with the new CDC ACIP guidelines. The PVAP popped up on the EMR anytime a new patient was admitted and prompted the NS to fill the checklist aiding them to screen for eligible patients(figure 2). We analyzed the effect on vaccination rate and compliance with ACIP guidelines pre and post PVAP launch. Compliance was defined as  the percent of patients who were eligible for the vaccine per the ACIP guidelines and were  administered the correct schedule of vaccines.

    Results:

    500 newly admitted adult patient (age >18) who met the ACIP pneumococcal vaccine criteria were selected via EMR search 6 months pre and post PVAP. Compliance rate pre PVAP ranged from 96 -98percentile. Post PVAP launch the vaccination rate continued to remain steady around the same range (Figure1).Also complete information on patients' immune status, risk factors and eligibility was easily accessible from a single screen in the EMR following the PVAP launch. PVAP was considered a user friendly and convenient tool by the NS.

    Conclusion:

    The pivotal role of pneumococcal vaccine on prevention of invasive pneumococcal infection is well known. However the new CDC APIC guidelines can be perplexing to NS especially in facility with higher patient volume. PVAP proved to be an efficient tool to aide NS to comply easily to the new ACIP recommendations.

    Figure 1 Vaccine compliance rate

    Figure 2 PVAP form1

    Figure 3 PVAP form 2

    Suganya Chandramohan, M.D., Department of Infectious Disease, Wayne state university, Detroit, MI, Amar Krishna, MD, Division of Infectious Disease, Wayne state university, Detroit, MI, David Trupiano, PharmD, Wayne state university, Detroit, MI, Paru Patel, Pharm D, 3990,John R St, 3990,John R St, Detroit, MI, Keith S. Kaye, MD, MPH, Detroit Medical Center, Detroit, MI and Teena Chopra, M.D. M.P.H, Infectious Diseases, Detroit Medical Center/Wayne State University, Detroit, MI

    Disclosures:

    S. Chandramohan, None

    A. Krishna, None

    D. Trupiano, None

    P. Patel, None

    K. S. Kaye, None

    T. Chopra, None

    Findings in the abstracts are embargoed until 12:01 a.m. CDT, Wednesday Oct. 26th with the exception of research findings presented at the IDWeek press conferences.